Celgene abandoned a key drug application last week, sending the stock and sector into a tailspin that could signal an intermediate correction. …read more
Read more here: Celgene Shocker Could End Biotech Rally
Category: CELG, IBB
Please enter your email to receive banking, savings, mortgage offers and newsletter about the latest financial events.